Le globule rouge - Un nouvel acteur dans la physiopathologie de la maladie de Gaucher

Mélanie Franco; Caroline Le Van Kim

doi:doi:10.1051/medsci/20132912008

Accès gratuit

Numéro		Med Sci (Paris) Volume 29, Numéro 12, Décembre 2013


Page(s)		1086 - 1088
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/20132912008
Publié en ligne		20 décembre 2013

Cox TM, Schofield JP. Gaucher’s disease: clinical features and natural history. Baillieres Clin Haematol 1997 ; 10 : 657–689. [CrossRef] [PubMed]
Stowens DW, Teitelbaum SL, Kahn AJ, Barranger JA. Skeletal complications of Gaucher disease. Medicine 1985 ; 64 : 310–322. [CrossRef] [PubMed]
Cartron JP, Elion J. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transf Clin Biol 2008 ; 15 : 39–50. [CrossRef]
Nash GB, Johnson CS, Meiselman HJ. Rheologic impairment of sickle RBCs induced by repetitive cycles of deoxygenation-reoxygenation. Blood 1988 ; 72 : 539–545. [PubMed]
Bratosin D, Tissier JP, Lapillonne H, et al. A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis. Cytometry B Clin Cytom 2011 ; 80 : 28–37. [CrossRef] [PubMed]
Nilsson O, Hakansson G, Dreborg S, et al. Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III. Clin Genet 1982 ; 22 : 274–279. [CrossRef] [PubMed]
Franco M, Collec E, Connes P, et al. Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease. Blood 2013 ; 121 : 546–555. [CrossRef] [PubMed]
Gauthier E, El Nemer W, Wautier MP, et al. Role of the interaction between Lu/BCAM and the spectrin-based membrane skeleton in the increased adhesion of hereditary spherocytosis red cells to laminin. Br J Haematol 2010 ; 148 : 456–465. [CrossRef] [PubMed]
Bartolucci P, Chaar V, Picot J, et al. Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation. Blood 2010 ; 116 : 2152–2159. [CrossRef] [PubMed]
Groener JE, Poorthuis BJ, Kuiper S, et al. Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention. Biochem Biophys Acta 2008 ; 1781 : 72–78. [CrossRef]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Cox TM, Schofield JP. Gaucher’s disease: clinical features and natural history. Baillieres Clin Haematol 1997 ; 10 : 657–689. [CrossRef] [PubMed]

[2] Stowens DW, Teitelbaum SL, Kahn AJ, Barranger JA. Skeletal complications of Gaucher disease. Medicine 1985 ; 64 : 310–322. [CrossRef] [PubMed]

[3] Cartron JP, Elion J. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transf Clin Biol 2008 ; 15 : 39–50. [CrossRef]

[4] Nash GB, Johnson CS, Meiselman HJ. Rheologic impairment of sickle RBCs induced by repetitive cycles of deoxygenation-reoxygenation. Blood 1988 ; 72 : 539–545. [PubMed]

[5] Bratosin D, Tissier JP, Lapillonne H, et al. A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis. Cytometry B Clin Cytom 2011 ; 80 : 28–37. [CrossRef] [PubMed]

[6] Nilsson O, Hakansson G, Dreborg S, et al. Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III. Clin Genet 1982 ; 22 : 274–279. [CrossRef] [PubMed]

[7] Franco M, Collec E, Connes P, et al. Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease. Blood 2013 ; 121 : 546–555. [CrossRef] [PubMed]

[8] Gauthier E, El Nemer W, Wautier MP, et al. Role of the interaction between Lu/BCAM and the spectrin-based membrane skeleton in the increased adhesion of hereditary spherocytosis red cells to laminin. Br J Haematol 2010 ; 148 : 456–465. [CrossRef] [PubMed]

[9] Bartolucci P, Chaar V, Picot J, et al. Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation. Blood 2010 ; 116 : 2152–2159. [CrossRef] [PubMed]

[10] Groener JE, Poorthuis BJ, Kuiper S, et al. Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention. Biochem Biophys Acta 2008 ; 1781 : 72–78. [CrossRef]